Cargando…
Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge
BACKGROUND: Myocardial hypertrophy and dysfunction are key features of metabolic heart disease due to dietary excess. Metabolic heart disease manifests primarily as diastolic dysfunction but may progress to systolic dysfunction, although the mechanism is poorly understood. Liver kinase B1 (LKB1) is...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859355/ https://www.ncbi.nlm.nih.gov/pubmed/26722122 http://dx.doi.org/10.1161/JAHA.115.002277 |
_version_ | 1782430949668028416 |
---|---|
author | Miller, Edward J. Calamaras, Timothy Elezaby, Aly Sverdlov, Aaron Qin, Fuzhong Luptak, Ivan Wang, Ke Sun, Xinxin Vijay, Andrea Croteau, Dominique Bachschmid, Markus Cohen, Richard A. Walsh, Kenneth Colucci, Wilson S. |
author_facet | Miller, Edward J. Calamaras, Timothy Elezaby, Aly Sverdlov, Aaron Qin, Fuzhong Luptak, Ivan Wang, Ke Sun, Xinxin Vijay, Andrea Croteau, Dominique Bachschmid, Markus Cohen, Richard A. Walsh, Kenneth Colucci, Wilson S. |
author_sort | Miller, Edward J. |
collection | PubMed |
description | BACKGROUND: Myocardial hypertrophy and dysfunction are key features of metabolic heart disease due to dietary excess. Metabolic heart disease manifests primarily as diastolic dysfunction but may progress to systolic dysfunction, although the mechanism is poorly understood. Liver kinase B1 (LKB1) is a key activator of AMP‐activated protein kinase and possibly other signaling pathways that oppose myocardial hypertrophy and failure. We hypothesized that LKB1 is essential to the heart's ability to withstand the metabolic stress of dietary excess. METHODS AND RESULTS: Mice heterozygous for cardiac LKB1 were fed a control diet or a high‐fat, high‐sucrose diet for 4 months. On the control diet, cardiac LKB1 hearts had normal structure and function. After 4 months of the high‐fat, high‐sucrose diet, there was left ventricular hypertrophy and diastolic dysfunction in wild‐type mice. In cardiac LKB1 (versus wild‐type) mice, high‐fat, high‐sucrose feeding caused more hypertrophy (619 versus 553 μm(2), P<0.05), the de novo appearance of systolic dysfunction (left ventricular ejection fraction; 41% versus 59%, P<0.01) with left ventricular dilation (3.6 versus 3.2 mm, P<0.05), and more severe diastolic dysfunction with progression to a restrictive filling pattern (E/A ratio; 5.5 versus 1.3, P=0.05). Myocardial dysfunction in hearts of cardiac LKB1 mice fed the high‐fat, high‐sucrose diet was associated with evidence of increased apoptosis and apoptotic signaling via caspase 3 and p53/PUMA (p53 upregulated modulator of apoptosis) and more severe mitochondrial dysfunction. CONCLUSIONS: Partial deficiency of cardiac LKB1 promotes the adverse effects of a high‐fat, high‐sucrose diet on the myocardium, leading to worsening of diastolic function and the de novo appearance of systolic dysfunction. LKB1 plays a key role in protecting the heart from the consequences of metabolic stress. |
format | Online Article Text |
id | pubmed-4859355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-48593552016-05-20 Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge Miller, Edward J. Calamaras, Timothy Elezaby, Aly Sverdlov, Aaron Qin, Fuzhong Luptak, Ivan Wang, Ke Sun, Xinxin Vijay, Andrea Croteau, Dominique Bachschmid, Markus Cohen, Richard A. Walsh, Kenneth Colucci, Wilson S. J Am Heart Assoc Original Research BACKGROUND: Myocardial hypertrophy and dysfunction are key features of metabolic heart disease due to dietary excess. Metabolic heart disease manifests primarily as diastolic dysfunction but may progress to systolic dysfunction, although the mechanism is poorly understood. Liver kinase B1 (LKB1) is a key activator of AMP‐activated protein kinase and possibly other signaling pathways that oppose myocardial hypertrophy and failure. We hypothesized that LKB1 is essential to the heart's ability to withstand the metabolic stress of dietary excess. METHODS AND RESULTS: Mice heterozygous for cardiac LKB1 were fed a control diet or a high‐fat, high‐sucrose diet for 4 months. On the control diet, cardiac LKB1 hearts had normal structure and function. After 4 months of the high‐fat, high‐sucrose diet, there was left ventricular hypertrophy and diastolic dysfunction in wild‐type mice. In cardiac LKB1 (versus wild‐type) mice, high‐fat, high‐sucrose feeding caused more hypertrophy (619 versus 553 μm(2), P<0.05), the de novo appearance of systolic dysfunction (left ventricular ejection fraction; 41% versus 59%, P<0.01) with left ventricular dilation (3.6 versus 3.2 mm, P<0.05), and more severe diastolic dysfunction with progression to a restrictive filling pattern (E/A ratio; 5.5 versus 1.3, P=0.05). Myocardial dysfunction in hearts of cardiac LKB1 mice fed the high‐fat, high‐sucrose diet was associated with evidence of increased apoptosis and apoptotic signaling via caspase 3 and p53/PUMA (p53 upregulated modulator of apoptosis) and more severe mitochondrial dysfunction. CONCLUSIONS: Partial deficiency of cardiac LKB1 promotes the adverse effects of a high‐fat, high‐sucrose diet on the myocardium, leading to worsening of diastolic function and the de novo appearance of systolic dysfunction. LKB1 plays a key role in protecting the heart from the consequences of metabolic stress. John Wiley and Sons Inc. 2015-12-31 /pmc/articles/PMC4859355/ /pubmed/26722122 http://dx.doi.org/10.1161/JAHA.115.002277 Text en © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Miller, Edward J. Calamaras, Timothy Elezaby, Aly Sverdlov, Aaron Qin, Fuzhong Luptak, Ivan Wang, Ke Sun, Xinxin Vijay, Andrea Croteau, Dominique Bachschmid, Markus Cohen, Richard A. Walsh, Kenneth Colucci, Wilson S. Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge |
title | Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge |
title_full | Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge |
title_fullStr | Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge |
title_full_unstemmed | Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge |
title_short | Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge |
title_sort | partial liver kinase b1 (lkb1) deficiency promotes diastolic dysfunction, de novo systolic dysfunction, apoptosis, and mitochondrial dysfunction with dietary metabolic challenge |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859355/ https://www.ncbi.nlm.nih.gov/pubmed/26722122 http://dx.doi.org/10.1161/JAHA.115.002277 |
work_keys_str_mv | AT milleredwardj partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT calamarastimothy partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT elezabyaly partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT sverdlovaaron partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT qinfuzhong partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT luptakivan partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT wangke partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT sunxinxin partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT vijayandrea partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT croteaudominique partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT bachschmidmarkus partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT cohenricharda partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT walshkenneth partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge AT colucciwilsons partialliverkinaseb1lkb1deficiencypromotesdiastolicdysfunctiondenovosystolicdysfunctionapoptosisandmitochondrialdysfunctionwithdietarymetabolicchallenge |